Cargando…
Percutaneous intraductal radiofrequency ablation in the management of unresectable Bismuth types III and IV hilar cholangiocarcinoma
PURPOSE: To assess the feasibility and safety of percutaneous intraductal radiofrequency ablation (RFA) for unresectable Bismuth types III and IV hilar cholangiocarcinoma. RESULTS: Percutaneous intraductal RFA combined with metal stent placement was successful in all patients without any technical p...
Autores principales: | Wang, Yu, Cui, Wei, Fan, Wenzhe, Zhang, Yingqiang, Yao, Wang, Huang, Kunbo, Li, Jiaping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288231/ https://www.ncbi.nlm.nih.gov/pubmed/27322076 http://dx.doi.org/10.18632/oncotarget.10116 |
Ejemplares similares
-
The safety and efficacy of percutaneous intraductal radiofrequency ablation in unresectable malignant biliary obstruction: A single-institution experience
por: Cui, Wei, et al.
Publicado: (2017) -
Palliative treatment with radiation-emitting metallic stents in unresectable Bismuth type III or IV hilar cholangiocarcinoma
por: Lu, Jian, et al.
Publicado: (2017) -
Transhepatic hilar approach for Bismuth types III and IV perihilar cholangiocarcinoma with long-term outcomes
por: Xu, Xinsen, et al.
Publicado: (2021) -
Treatment of hilar cholangiocarcinoma of Bismuth-Corlette type III with hepaticojejunostomy
por: Lu, Bao-Chun, et al.
Publicado: (2013) -
Clinical impact of irreversible electroporation ablation for unresectable hilar cholangiocarcinoma
por: Hsiao, Chih-Yang, et al.
Publicado: (2020)